ECO ANIMAL HEALTH GROUP PLC

Regulatory Filings • May 11, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

ECO Animal Health Group plc

(AIM: EAH)

ECO RECEIVES AIVLOSIN® AND ECOMECTIN® MARKETING AUTHORISATIONS IN THE UNITED ARAB EMIRATES

ECO is pleased to announce that it has received three marketing authorisations in the United Arab Emirates (UAE) for Aivlosin® Water Soluble Granules for poultry, Ecomectin® Injection and Ecomectin® Horse Paste.

Aivlosin®, ECO’s patented antibacterial, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in poultry.

Ecomectin®, ECO’s European range of antiparasitic products includes an injection licensed for the treatment of cattle and sheep, a pour-on for cattle and a paste formulation for horses.

Peter Lawrence, Chairman of ECO, commented, “These marketing authorisations in the UAE, a key member of the Gulf Cooperation Council, should support the process of obtaining further marketing authorisations in the Kingdom of Saudi Arabia which is a very important poultry market. It underlines ECO’s continued commitment to being a major force in the international market for veterinary pharmaceutical products.”

Contacts:
ECO Animal Health Group plc				Peter Lawrence		020 8336 6190
				Marc Loomes		020 8447 8899
Spiro Financial				Anthony Spiro		020 8336 6196
Peel Hunt LLP				Dan Webster		020 7418 8900
(Nominated Adviser)

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.